Suven Life Sciences Ltd Quarterly Results

Gross Sales

0.92

1.87

1.47

1.61

2.57

Excise Duty

0

0

0

0

0

Net Sales

0.92

1.87

1.47

1.61

2.57

Other Operating Income

0

0

0

0

0

Other Income

3.78

0.6

1.22

1.63

4.04

Total Income

4.7

2.47

2.69

3.24

6.61

Total Expenditure

80.69

52.62

45.29

40.82

54.78

PBIDT

-75.99

-50.15

-42.6

-37.58

-48.17

Interest

0

0

0

0.01

0.02

PBDT

-75.99

-50.15

-42.6

-37.58

-48.19

Depreciation

1.32

1.37

1.35

1.53

1.46

Minority Interest Before NP

0

0

0

0

0

Tax

0

0

0

0

0

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

-77.31

-51.52

-43.94

-39.12

-49.64

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

-77.31

-51.52

-43.94

-39.12

-49.64

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

-77.31

-51.52

-43.94

-39.12

-49.64

EPS (Unit Curr.)

-3.48

-2.36

-2.02

-1.79

-2.27

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

22.74

21.81

21.81

21.81

21.81

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

-8,259.78

-2,681.81

-2,897.95

-2,334.16

-1,874.31

PBDTM(%)

-8,259.78

-2,681.81

-2,897.95

-2,334.16

-1,875.09

PATM(%)

-8,403.26

-2,755.08

-2,989.11

-2,429.81

-1,931.51